Stryker's Mako franchise makes it one of the clearest scaled robotics names in orthopedics.
Side-by-side research view
Compare names across metrics and research quality
Use up to 4 U.S.-listed names from this dashboard to compare valuation, growth, cash flow, balance-sheet strength, and the curated investment case in one place.
1 stocks in current compare
4 max names side by side
25 shared metrics lined up
Build a compare set
Enter comma-separated tickers from the dashboard universe. Duplicate tickers are ignored automatically.
Price
$310.72
1D change
+0.35%
Market cap
$118.29B
Sector
Healthcare
| Metric | SYK |
|---|---|
| Price | $310.72 |
| 1D Change | +0.35% |
| Market Cap | $118.29B |
| Enterprise Value | $130.45B |
| Trailing P/E | 33.1 |
| Forward P/E | 19.1 |
| PEG Ratio | 1.49x |
| Price / Sales | 4.5 |
| EV / Revenue | 5.0 |
| Revenue Growth | 7.6% |
| Earnings Growth | -11.7% |
| Gross Margin | 65.7% |
| Operating Margin | 24.0% |
| Net Margin | 13.8% |
| ROE | 16.0% |
| Free Cash Flow | $3.70B |
| FCF Margin | 14.1% |
| Debt / Equity | 0.66x |
| Current Ratio | 2.18x |
| Dividend Yield | 1.13% |
| Next Earnings | Jan 28, 2027 |
| Quarterly Revenue | $6.52B |
| Revenue QoQ | -1.0% |
| Quarterly Net Income | $753.0M |
| Net Income QoQ | -41.0% |
SYK thesis lens
Orthopedic robotics platform
Why it could benefit
- Stryker's Mako franchise makes it one of the clearest scaled robotics names in orthopedics.
- Recent expansion into handheld robotics broadens the Mako platform and gives the sleeve another real medical-robotics leader.
- It adds exposure to hospital robotics without relying on the exact same thesis as Intuitive.
Moat / edge
- Established Mako installed base and surgeon workflow integration.
- Strong orthopedic distribution and clinical relationships.
- A robotics platform that can expand across procedures over time.
What to watch
- Mako placements and utilization.
- Adoption of new handheld robotics offerings.
- How much robotics continues to differentiate Stryker in orthopedics.
Key risks
- Hospital budgets and elective procedure trends can affect demand.
- The robotics narrative is important, but it still sits inside a broader medtech company.